Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

Muller, Alexander J, DuHadaway, James B, Donover, P Scott, Sutanto-Ward, Erika, Prendergast, George C·2005·Nature Medicine

DOI 10.1038/nm1196

Cited by (999)

Items 501–600 of 999

Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells
Yuwen He, Hongsheng Wang, Jun Zeng, Xiefan Fang, Hong‐Yuan Chen, Jun Du, Xinyun Yang · 2013 · Life Sciences
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, Frédéric Sapunaric, Bernadette Norberg, Laurence Moineaux, Delphine Colette, Vincent Stroobant, Luc Pilotte, Didier Colau et al. · 2010 · Bioorganic & Medicinal Chemistry
Necroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells
Sara Melo-Lima, María Celeste Lopes, Faustino Mollinedo · 2014 · Oncoscience
Shaping the Glioma Immune Microenvironment Through Tryptophan Metabolism
Michael Platten, Michael Weller, Wolfgang Wick · 2012 · CNS Oncology
4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth
Subhankar Panda, Nirmalya Pradhan, Soumya Chatterjee, Sudhir Morla, Abhishek Saha, Ashalata Roy, Sachin Kumar, Arindam Bhattacharyya, Debasis Manna · 2019 · Scientific Reports
Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells
Hannah Jonescheit, Hans‐Heinrich Oberg, Daniel Gonnermann, Martin Hermes, Vjola Sulaj, Christian Peters, Dieter Kabelitz, Daniela Wesch · 2020 · Cells
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Sayani Patra, Naveed Elahi, Aaron Armorer, Swathi Arunachalam, Joshua Omala, Iman Hamid, Anthony W. Ashton, David A. Joyce, Xuanmao Jiao, Richard G. Pestell · 2021 · Frontiers in Oncology
Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives
Cécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, Cindy Neuzillet, Victoire Cardot‐Ruffino · 2022 · Cancers
Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer
Kazuhiko Ino · 2010 · Current Opinion in Obstetrics & Gynecology
Spectroscopic Studies of Ligand and Substrate Binding to Human Indoleamine 2,3-Dioxygenase
Changyuan Lu, Yu Hong Lin, Syun‐Ru Yeh · 2010 · Biochemistry
Persistent infectious diseases say – IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy
Heidi Barth, Sukanya Raghuraman · 2012 · Critical Reviews in Microbiology
High-Throughput Fluorescence-Based Screening Assays for Tryptophan-Catabolizing Enzymes
Nicole Willemsen‐Seegers, Antoon M. van Doornmalen, Joost C.M. Uitdehaag, Jos de Man, Rogier C. Buijsman, Guido J.R. Zaman · 2014 · SLAS DISCOVERY
O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1
William P. Malachowski, Maria Winters, James B. DuHadaway, Ariel Lewis-Ballester, Shorouk Badir, Jenny Wai, Maisha Rahman, Eesha Sheikh, Judith M. LaLonde, Syun‐Ru Yeh et al. · 2015 · European Journal of Medicinal Chemistry
The importance of correctly timing cancer immunotherapy
Elham Beyranvand Nejad, Marij J.P. Welters, Ramon Arens, Sjoerd H. van der Burg · 2016 · Expert Opinion on Biological Therapy
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model
Xiangjing Meng, Guangying Du, Liang Ye, Shanyue Sun, Qiaofeng Liu, Hongbo Wang, Wenyan Wang, Zimei Wu, Jingwei Tian · 2017 · International Journal of Immunopathology and Pharmacology
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
Anne Marijne Heeren, Ilse van Dijk, Daniella R. A. I. Berry, Maryam Khelil, Debbie M. Ferns, Jeroen Kole, René J.P. Musters, Victor L. Thijssen, Constantijne Helene Mom, Gemma G. Kenter et al. · 2018 · Frontiers in Immunology
Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase
Khoa Pham, Ariel Lewis-Ballester, Syun‐Ru Yeh · 2019 · Journal of the American Chemical Society
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802
Sanjeev Kumar, Firoz Ali Jaipuri, Jesse P. Waldo, Hima Potturi, Agnieszka Marcinowicz, James Adams, Clarissa Van Allen, Hong Zhuang, Nicholas N. Vahanian, Charles Link et al. · 2020 · European Journal of Medicinal Chemistry
Total Synthesis of Exiguamines A and B Inspired by Catecholamine Chemistry
Vladimir Sofiyev, Jean‐Philip Lumb, Matthew Volgraf, Dirk H. Trauner · 2012 · Chemistry - A European Journal
NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes
Andrew S. Marriott, Olga Vasieva, Yongxiang Fang, Nikki A. Copeland, Alexander G. McLennan, Nigel J. Jones · 2016 · PLoS ONE
Immunotherapy for breast cancer: past, present, and future
Alison Spellman, Shou-Ching Tang · 2016 · Cancer and Metastasis Reviews
Epigenomics and immunotherapeutic advances in pediatric brain tumors
Malak Abedalthagafi, Nahla Ali Mobark, May Mohammed Alrashed, Musa Alharbi · 2021 · npj Precision Oncology
Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
Shivani Krishnamurthy, David Gilot, Seong Beom Ahn, Vincent K. L. Lam, Joo‐Shik Shin, Gilles J. Guillemin, Benjamin Heng · 2021 · Cancers
Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity
Million Arefayene, Santosh Philips, Donghua Cao, SudhaRani Mamidipalli, Zeruesenay Desta, David Alastair Flockhart, David S. Wilkes, Todd C. Skaar · 2009 · Pharmacogenetics and Genomics
Exploring tryptophan metabolism: The transition from disturbed balance to diagnostic and therapeutic potential in metabolic diseases
Zhizhong Luo, Yuqing Liu, Xin Wang, Faxin Fan, Zhenzhen Yang, Duosheng Luo · 2024 · Biochemical Pharmacology
Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells
Guang Yu, Min Fang, Min Gong, Li Liu, Jixin Zhong, Wei Feng, Ping Xiong, Cong‐Yi Wang, Feili Gong · 2007 · Transplant Immunology
Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer
Francisco Stefânio Barreto, Adriano José Maia Chaves Filho, Márcia Cristiane Araújo, Manoel O. de Moraes, Maria Elisabete Amaral de Moraes, Michael H. J. Maes, David Freitas de Lucena, Danielle S. Macêdo · 2018 · Behavioural Pharmacology
New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
Nicolas Villanueva, Lyudmila A. Bazhenova · 2018 · Therapeutic Advances in Respiratory Disease
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ
Takumi Kudo, Mirja Tamara Prentzell, Soumya R. Mohapatra, Felix Sahm, Zhongliang Zhao, Ingrid Grummt, Wolfgang Wick, Christiane A. Opitz, Michael Platten, Edward W. Green · 2020 · Frontiers in Immunology
Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1
Erik L. Brincks, James Adams, Lifu Wang, Benjamin A. Turner, Agnieszka Marcinowicz, Jiyuan Ke, Michael Essmann, Lucía M. Mautino, Clarissa Van Allen, Sanjeev Kumar et al. · 2020 · Oncotarget
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
Tiziana Di Pucchio, Silvio Danese, Raimondo DE CRISTOFARO, Sergio Rutella · 2010 · Expert Opinion on Therapeutic Patents
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer
Dyah Laksmi Dewi, Soumya R. Mohapatra, Saioa Blanco, Isabell Adam, Luis F. Somarribas Patterson, Bianca Berdel, Masroor Kahloon, Loreen Thürmann, Stefanie Loth, Katharina Heilmann et al. · 2017 · OncoImmunology
Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative disease
Ki-Hong Jang, Yun‐Ju Do, Tae‐Sung Koo, Jun‐Sub Choi, Eun Ju Song, Yeseong Hwang, Hyun Ju Bae, Ju-hee Lee, Eunhee Kim · 2018 · Experimental Eye Research
Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
K. Asghar, A. Loya, Iftikhar Ali Rana, M. Tahseen, M. Ishaq, Asim Farooq, M. A. Bakar, Iqra Masood · 2019 · Cancer Management and Research
Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer
Jian Gao, Fusheng Deng, Wei-Dong Jia · 2019 · Journal of Breast Cancer
Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Xiuxiu Wang, Si-Yu Sun, Qing-Qing Dong, Xiao-xiang Wu, Wei Tang, Ya-Qun Xing · 2019 · MedChemComm
Advancements in immune tolerance
Ping‐Ying Pan, Junko J. Ozao, Zuping Zhou, Shu‐Hsia Chen · 2007 · Advanced Drug Delivery Reviews
Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
Siyan Liu, Jing Li, Lin Gu, Kun-Zhe Wu, Xing Hua · 2022 · International Journal of Nanomedicine
Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells
Zujun Que, Fangyuan Zou, Anle Zhang, Yuanhong Zheng, Ling Bi, Jian‐Jiang Zhong, Jianhui Tian, Jianwen Liu · 2014 · International Immunopharmacology
Immune Sculpting of Norepinephrine on MHC-I, B7-1, IDO and B7-H1 Expression and Regulation of Proliferation and Invasion in Pancreatic Carcinoma Cells
Liancai Wang, Han Liu, Xiangli Chen, Min Zhang, Keping Xie, Qingyong Ma · 2012 · PLoS ONE
Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
Daniel Delitto, Shannon Margaret Wallet, Steven J. Hughes · 2016 · Pharmacology & Therapeutics
Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells
Azubuike Peter Ebokaiwe, Emmanuel Mfotie Njoya, Yuwen Sheng, Zhonghui Zhang, Sheng Li, Zongyuan Zhou, Zhe Qiang, Ting Peng, Ahmed Abdullah Hussein, Guolin Zhang et al. · 2020 · Toxicology and Applied Pharmacology
The emerging roles of IDO2 in cancer and its potential as a therapeutic target
Pengcheng Li, Weiqi Xu, Furong Liu, He Zhu, Lu Zhang, Zeyang Ding, Huifang Liang, Jia Song · 2021 · Biomedicine & Pharmacotherapy
HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
Andris M. Evans, Mikhail Y. Salnikov, Steven F. Gameiro, Saman Maleki Vareki, Joe S. Mymryk · 2022 · Journal of Clinical Medicine
Cytochrome b5 is a major reductant in vivo of human indoleamine 2,3‐dioxygenase expressed in yeast
Eduardo Vottero, David A. Mitchell, Michael J. Page, Ross T. A. MacGillivray, Ivan Sadowski, Michel Roberge, A. Grant Mauk · 2006 · FEBS Letters
Necrostatin-1 rescues mice from lethal irradiation
Zhentai Huang, Michael W. Epperly, Simon C. Watkins, Joel S. Greenberger, Valerian E. Kagan, Hülya Bayır · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer
Le Zhang, Shiwei Fan, Julio Vera, Xin Lai · 2022 · Computational and Structural Biotechnology Journal
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
Nouria Jantz-Naeem, Romy Loschinski, Katrin Borucki, Marisa Mitchell-Flack, Martin Böttcher, Burkhart L. Schraven, Dimitrios Mougiakakos, Sascha Kahlfuß · 2023 · Frontiers in Oncology
Harnessing the immune system for the treatment of breast cancer
Xinguo Jiang · 2014 · Journal of Zhejiang University SCIENCE B
Enhancing the efficacy of cancer vaccines in urologic oncology: new directions
Sergei A. Kusmartsev, Johannes Vieweg · 2009 · Nature Reviews Urology
A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity
Huei‐Jiun Yang, Meng‐Chi Yen, Chi‐Chen Lin, Chiu-Mei Lin, Yi‐Ling Chen, Tzu‐Yang Weng, Tzu‐Ting Huang, Chao‐Liang Wu, Ming-Derg Lai · 2010 · Experimental Biology and Medicine
Immunotherapy Strategies in the Treatment of Breast Cancer
Hatem H. Soliman · 2013 · Cancer Control
Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice
Motamed Elsayed Mahmoud, Ragab M. Fereig, Yoshifumi Nishikawa · 2017 · Infection and Immunity
Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells
Yoshinari Ozawa, Shun Yamamuro, Emiko Sano, Juri Tatsuoka, Yuya Hanashima, Sodai Yoshimura, Koichiro Sumi, Hiroyuki Hara, Tomohiro Nakayama, Yutaka Suzuki et al. · 2020 · Biochemical and Biophysical Research Communications
Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib
Christin Riess, Björn Schneider, H Kehnscherper, Julia Gesche, Nina Irmscher, Fatemeh Shokraie, Carl Friedrich Classen, Elisa Wirthgen, Grażyna Domańska, Annette Zimpfer et al. · 2020 · Frontiers in Immunology
Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties
Christopher J. D. Austin, Florian Astelbauer, Priambudi Kosim-Satyaputra, H. Ball, R. Willows, J. Jamie, N. Hunt · 2008 · Amino Acids
Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer
Anna Maria Passarelli, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Sabrina Rossetti, Rosa Tambaro, Jole Ventriglia, Federica Gherardi, Eva Iannacone, Sergio Venanzio Setola et al. · 2022 · Frontiers in Immunology
Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer
Xiaojie Liu, Lu Liu, Xu Wang, Yubin Jin, Shuang Wang, Xie Qin, Yanhe Jin, Mengli Zhang, Yunhe Liu, Jinfeng Li et al. · 2023 · Phytomedicine
Metformin reprograms tryptophan metabolism via gut microbiome-derived bile acid metabolites to ameliorate depression-Like behaviors in mice
Xiaoxian Xie, Wenwen Li, Ze Xiong, Junyu Xu, Tailin Liao, Lei Sun, Haoshen Xu, Mengya Zhang, Jiafeng Zhou, Wenzheng Xiong et al. · 2024 · Brain Behavior and Immunity
Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors
Minoru Tanaka, Xin Li, Hidemasa Hikawa, Takafumi Suzuki, Katsuhiko Tsutsumi, Masashi Sato, Osamu Takikawa, Hideharu Suzuki, Yuusaku Yokoyama · 2013 · Bioorganic & Medicinal Chemistry
Harnessing the immune system in the battle against breast cancer
Elizabeth S. Nakasone, Sara Alsterlind Hurvitz, Kelly Elizabeth McCann · 2018 · Drugs in Context
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer
Giulia Stazi, Rossella Fioravanti, Antonello Mai, Andrea Mattevi, Sérgio Valente · 2019 · Current Opinion in Chemical Biology
Panax notoginseng saponins prevent colitis-associated colorectal cancer via inhibition IDO1 mediated immune regulation
Xue-Ming LI, Ding-Yi YUAN, Ya-Hui LIU, Lei ZHU, Hong-Kun QIN, Yu-Bing YANG, Yan LI, Fang YAN, Ya-Jing WANG · 2022 · Chinese Journal of Natural Medicines
Metabolic guidance and stress in tumors modulate antigen-presenting cells
Jaeoh Park, Limei Wang, Ping‐Chih Ho · 2022 · Oncogenesis
Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated
Arian Charehjoo, Jamal Majidpoor, Keywan Mortezaee · 2023 · International Immunopharmacology
Process of hepatic metastasis from pancreatic cancer: biology with clinical significance
Haojun Shi, Ji Li, Deliang Fu · 2015 · Journal of Cancer Research and Clinical Oncology
Small molecule drugs with immunomodulatory effects in cancer
Adrian Gerard Murphy, Lei Zheng · 2015 · Human Vaccines & Immunotherapeutics
Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests
Jacek Jan Sznurkowski, Anton Żawrocki, Janusz Emerich, Katarzyna Sznurkowska, Wojciech Biernat · 2011 · Gynecologic Oncology
Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells
Noura M. El-kholy, Maha Mohamed Sallam, Manal Basyouni Ahmed, Reem M. Sallam, Inas Ahmed Asfour, Jehad A. Hammouda, Haidy Habib, Fatima Abu-Zahra · 2010 · Medical Oncology
Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: pharmacophore modeling and molecular docking studies.
Shalini John, S. Thangapandian, S. Sakkiah, K. Lee · 2010 · European journal of medicinal chemistry
The Tumor Microenvironment: Part 1
Judith Leibovici, Orit Itzhaki, Monica Huszar, Judith Sinai · 2011 · Immunotherapy
Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy
Seon Ah Lim · 2024 · BMB Reports
Targeting amino acid-metabolizing enzymes for cancer immunotherapy
Yvonne Grobben · 2024 · Frontiers in Immunology
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy
Simone Ielpo, Francesca Barberini, Farnaz Dabbagh Moghaddam, Silvia Pesce, Chiara Cencioni, Francesco Spallotta, Adele De Ninno, Luca Businaro, Emanuela Marcenaro, Roberto Bei et al. · 2024 · Cancer Treatment Reviews
Induction of Indoleamine 2, 3-Dioxygenase in Human Dendritic Cells by a Cholera Toxin B Subunit—Proinsulin Vaccine
Jacques C. Mbongue, Dequina Nicholas, Kangling Zhang, Nan-Sun Kim, Brittany N. Hamilton, Marco Larios, Guangyu Zhang, Kazuo Umezawa, Anthony Francis Firek, William H. R. Langridge · 2015 · PLoS ONE
Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications
Lucía Álvarez, A. Lewis-Ballester, A. Roitberg, D. Estrin, Syun-Ru Yeh, M. Marti, L. Capece · 2016 · Biochemistry
Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier
Qianyu Zhai, Yichao Chen, Jieni Xu, Yixian Huang, Jingjing Sun, Yanhua Liu, Xiaolan Zhang, Song Li, Suo-Qin Tang · 2017 · Molecular Pharmaceutics
Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold
Michael G. Brant, Jake Goodwin‐Tindall, Kurt R. Stover, Paul M. Stafford, Fan Wu, Autumn R. Meek, Paolo Schiavini, Stephanie Wohnig, Donald Fredric Weaver · 2018 · ACS Medicinal Chemistry Letters
The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma
Huijie Jia, Wenjing Ren, Yuchen Feng, Tian Wei, Mengmeng Guo, Jing Guo, Jingjing Zhao, Xiangfeng Song, Mingyong Wang, Tiesuo Zhao et al. · 2018 · International Journal of Oncology
FoxP3 and IDO in Canine Melanocytic Tumors
Ilaria Porcellato, Chiara Brachelente, Livia De Paolis, Laura Menchetti, Serenella Silvestri, Monica Sforna, Gaia Vichi, Selina Iussich, Luca Mechelli · 2018 · Veterinary Pathology
Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?
Clement Gascua Adu-Gyamfi, Dana M. Savulescu, Jaya A. George, Melinda Shelley Suchard · 2019 · Frontiers in Cellular and Infection Microbiology
Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors
Rahul Prasad Singh, Deepak B. Salunke · 2020 · European Journal of Medicinal Chemistry
Peritoneal macrophages suppress T‐cell activation by amino acid catabolism
Robin Matlack, K. Yeh, Laura Rosini, Diana González, Justin J. Taylor, Daniel Silberman, Anthony L. Pennello, James Edward Riggs · 2006 · Immunology
Peripheral tolerance in CD8+ T cells
Mathangi Srinivasan, Kenneth A. Frauwirth · 2009 · Cytokine
Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens
Maneesh Mailankot, M. Staniszewska, H. Butler, M. Caprara, S. Howell, Ben-Lian Wang, Catherine M. Doller, L. Reneker, R. Nagaraj · 2009 · Laboratory Investigation
Zinc Protoporphyrin IX Stimulates Tumor Immunity by Disrupting the Immunosuppressive Enzyme Indoleamine 2,3-Dioxygenase
Richard A. Metz, James B. DuHadaway, Sonja Rust, David H. Munn, Alexander J. Muller, Mario R. Mautino, George C. Prendergast · 2010 · Molecular Cancer Therapeutics
Cardiac‐Specific Disruption of Bin1 in Mice Enables a Model of Stress‐ and Age‐Associated Dilated Cardiomyopathy
Lisa D. Laury‐Kleintop, Jennifer Mulgrew, Ido Heletz, Radu Alexandru Nedelcoviciu, Mee Young Chang, David M. Harris, Walter J. Koch, Michael D. Schneider, Alexander J. Muller, George C. Prendergast · 2015 · Journal of Cellular Biochemistry
Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment
Theodore S. Johnson, Tracy L. McGaha, David H. Munn · 2017 · Advances in experimental medicine and biology
miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase
Xiao‐Su Zhao, Yinuo Wang, Meng Lv, Yuan Kong, Hongxue Luo, Xiaoyang Ye, Qi Wu, Tongfeng Zhao, Yue-huan Hu, Hongyu Zhang et al. · 2016 · Oncotarget
In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines
Keli Lee Hippen, Roddy S. O’Connor, Amanda M. Lemire, Asim Saha, Eric Allan Hanse, N.C. Tennis, Sarah C. Merkel, Ameeta Kelekar, James L. Riley, Bruce L. Levine et al. · 2017 · American Journal of Transplantation
Recent developments in small molecule therapies for renal cell carcinoma
Minsoo Song · 2017 · European Journal of Medicinal Chemistry
Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell–Dependent Tumor Activity
Tsubasa Watanabe, Simone Gaedicke, Elena Guffart, Elke Firat, Gabriele Niedermann · 2019 · Clinical Cancer Research
Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach
David E. Williams, Raymond J. Andersen · 2019 · Natural Product Reports
The Immunomodulator 1-Methyltryptophan Drives Tryptophan Catabolism Toward the Kynurenic Acid Branch
Elisa Wirthgen, Anne K. Leonard, Christian Scharf, Grażyna Domańska · 2020 · Frontiers in Immunology
IDO Targeting in Sarcoma: Biological and Clinical Implications
Imane Nafia, Maud Toulmonde, Doriane Bortolotto, Assia Chaïbi, D. Bodet, Christophe Rey, Valérie Velasco, Claire B. Larmonier, Loïc Cerf, Julien Adam et al. · 2020 · Frontiers in Immunology
Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models
Nathaniel Sheng Hua Too, Nicholas Ching Wei Ho, Christabella Adine, Narayanan Gopalakrishna Iyer, Eliza Li Shan Fong · 2021 · Advanced Drug Delivery Reviews
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma
Amedeo Amedei, Elena Niccolai, Chiara Della Bella, Fabio Cianchi, Giacomo Trallori, Marisa Benagiano, Lapo Bencini, Marco Bernini, Marco Farsi, Renato Moretti et al. · 2009 · Cancer Immunology Immunotherapy
Crinum Latifolium Leave Extracts Suppress Immune Activation Cascades in Peripheral Blood Mononuclear Cells and Proliferation of Prostate Tumor Cells
M. Jenny, Angela Wondrak, E. Zvetkova, Tram Ngoc Phuong Nguyen, P. P. Phi, H. Schennach, Z. Culig, Florian Ueberall, D. Fuchs · 2011 · Scientia Pharmaceutica
Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases
PH Tan, AK Bharath · 2009 · Expert Opinion on Therapeutic Targets
Dendritic Cells in Cancer
Russell D. Salter, Michael R. Shurin · 2009 · Springer eBooks